Prestige Brands Tops Estimates

Prestige Brand Holdings beat The Street in fiscal Q3. Sales were up less than 2% to $200.2 million, higher than the $198.1 million than analysts had expected. Net income for the quarter was $28 million, up from $21.3 million a year ago.


Prestige Brands Holdings, Inc., through its subsidiaries, markets, sells, and distributes over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in North American OTC healthcare, international OTC healthcare, and household cleaning segments. The company's OTC healthcare products portfolio include 15 primary brands, such as Chloraseptic sore throat remedies, Clear Eyes eye drops, Compound W wart removers, Little Remedies pediatric products, The Doctor’s brand of oral care products, Efferdent and Effergrip denture products, Luden’s cough drops, Dramamine motion sickness products, BC and Goody’s analgesic powders, Beano gas prevention, Gaviscon antacids, Debrox ear drops, Monistat vaginal treatments and feminine care products, and Nix lice treatments.


Its OTC healthcare products portfolio also comprise Dermoplast first-aid products, New-Skin liquid bandage, Fiber Choice fiber laxative supplements, Ecotrin aspirin, e.p.t family planning products, Uristat urinary tract infection treatments, Fess nasal saline spray, and Hydralyte for dehydration and electrolyte replacement.


The company also offers household cleaning products consisting of Chore Boy scrubbing pads and sponges; Comet abrasive and non-abrasive powders, sprays, and creams; and Spic and Span dilutables, sprays for counter tops, and glass cleaners. It primarily offers its products to mass merchandisers, drug stores, and supermarkets, as well as club, convenience, and dollar stores. The company was founded in 1996 and is headquartered in Tarrytown, New York.